key: cord-0202468-zp7e9w5v
authors: Zadorozhny, Karina; Thoral, Patrick; Elbers, Paul; Cina, Giovanni
title: Out-of-Distribution Detection for Medical Applications: Guidelines for Practical Evaluation
date: 2021-09-30
journal: nan
DOI: nan
sha: 44af8bf22e3f6366892f40bf28416f57fe85a722
doc_id: 202468
cord_uid: zp7e9w5v

Detection of Out-of-Distribution (OOD) samples in real time is a crucial safety check for deployment of machine learning models in the medical field. Despite a growing number of uncertainty quantification techniques, there is a lack of evaluation guidelines on how to select OOD detection methods in practice. This gap impedes implementation of OOD detection methods for real-world applications. Here, we propose a series of practical considerations and tests to choose the best OOD detector for a specific medical dataset. These guidelines are illustrated on a real-life use case of Electronic Health Records (EHR). Our results can serve as a guide for implementation of OOD detection methods in clinical practice, mitigating risks associated with the use of machine learning models in healthcare.

When deploying a machine learning model in a high-risk environment such as healthcare, it is crucial to reduce the risks of giving an incorrect prediction. One of the most common causes of failures of a well-performing model is dissimilarity between training (in-distribution) data and data that the model is used on after deployment (Saria and Subbaswamy, 2019) . This problem is further exacerbated in a non-stationary medical environment: the performance of predictive models can drop drastically when evaluated on medical data collected just a couple of years removed from in-distribution data (Nestor et al., 2018) . The reason for this can be, for example, a change in the demographics of the target population, changes in treatment protocols, or changes in data collection procedures (Finlayson et al., 2021) . These examples constitute a covariate shift where feature distributions changed compared to in-distribution data (Shimodaira, 2000; Moreno-Torres et al., 2012) . For reliable use of prediction models in healthcare it is necessary to have the ability to detect these changes in real-time.

In the past five years, there has been a surge in methods for OOD detection and uncertainty quantification. Despite the progress, OOD detection methods often fail at flagging atypical inputs. While most studies have focus on image data (Ovadia et al., 2019; Nalisnick et al., 2019) , it has recently been shown that many OOD detection methods fail to distinguish OOD inputs on medical tabular data (Ulmer et al., 2020) .

While predictive models are tailored and tested on specific datasets, there is no universal way to evaluate OOD detection methods in practice. This gap impedes wide-spread implementation of OOD detection methods. In this paper, we provide a practical set of guidelines on how to select an OOD detector in a given medical AI application. Our specific contributions are the following:

• We describe how to take into account dataset-specific variables when evaluating OOD detector models in practice.

• We show how to test OOD detectors on distinct families of OOD groups that can be created from available data using inclusion-exclusion criteria and withholding samples during training.

• We describe how to to use interpretability tools to assess whether influential features that drive novelty predictions are clinically relevant.

• We provide an open-source repository that can be used to evaluate OOD detection methods for any mixed-type tabular dataset. 1 We illustrate these general principles on real-world EHR data from the Intensive Care Unit (ICU) of Amsterdam University Medical Centers (AmsterdamUMC) (Thoral et al., 2021) . We show that using the guidelines proposed in this paper, we can detect underperforming OOD detectors and select the best methods to be deployed in practice.

Despite the impressive performance of machine learning models, recent studies have 1. https://github.com/Giovannicina/selecting OOD detector highlighted the potential risks of undetected OOD data points in critical areas such as healthcare. Besides deliberate threats such as data poisoning and adversarial attacks (Papangelou et al., 2019; Finlayson et al., 2019; Mozaffari-Kermani et al., 2015) , deployed models can suffer from severe malfunction due to dataset shifts. Finlayson et al. (2021) described different scenarios that lead to dataset shifts in practice and highlighted the need for more robust and reliable models in healthcare.

To mitigate risks of failure due to dataset shift caused by covariate shifts (Bickel et al., 2009) , recent studies proposed a plethora of uncertainty quantification methods. These methods can be broadly divided into two groups based on the type of uncertainty they express. The first group uses predictive uncertainty (uncertainty about predictions) which is model-specific and indicates how confident a model is in its prediction (Ovadia et al., 2019) ; such uncertainty can be measured with a variety of metrics. Models in this category include Bayesian Neural Networks (Blundell et al., 2015) , Ensemble Neural Networks (Lakshminarayanan et al., 2017), or Monte Carlo Dropout (Gal and Ghahramani, 2016) . The second group of models, density estimators, expresses uncertainty about samples by learning the distribution of training data. Models such as Variational Autoencoder (VAE; Kingma and Welling, 2014; Ran et al., 2020) or Normalizing Flows (Rezende and Mohamed, 2015) can be used to flag samples with low likelihood under an estimated in-distribution function.

There has been only limited work published to date that focuses on the practical evaluation of OOD detection methods in real-world scenarios. Hendrycks et al. (2020) proposed a benchmark for OOD detection in the imaging domain that could replace smallscale datasets containing only a few classes with a more realistic high-scale multi-class anomaly segmentation task. Techapanurak and Okatani (2021) described practical tests of OOD detection in the imaging domain to aid the evaluation of models in real-world applications. However, no guidelines on how to test OOD detectors are available for medical tabular data. In this paper, we aim to close this gap between research studies and the practical implementation of OOD detection methods in a medical setting.

We first describe considerations that should be taken into account when choosing an OOD detector for a specific application. In Section 3.2, we put forward guidelines for creating tests to assess the performance of OOD detection methods.

The proposed OOD tests are illustrated on a real-world use case of EHR data of Ams-terdamUMC. Details about the dataset, experimental set-up, implemented models, and the way OOD groups were selected for this dataset are described in Appendix A.

It has been shown that models that utilize predictive uncertainty in a classification setting can be overconfident in their faulty predictions (Guo et al., 2017; Ovadia et al., 2019) . Specifically, a group of discriminator models assign high predictive confidence to regions with no training data (Hein et al., 2019; Ulmer and Cinà, 2021) . Given these findings, we advise using density estimators instead of models that express predictive uncertainty. While there is a growing interest in the limitations of density estimators for OOD detection (Nalisnick et al., 2019; Kirichenko et al., 2020; Zhang et al., 2021) , density models outperformed discriminator models on several OOD detection tasks on tabular medical data (Ulmer et al., 2020) .

Many density estimators can perform well on continuous data but are not directly suitable for discrete distributions. Research efforts of extending models to discrete distributions most commonly focus on text inputs (Tran et al., 2019; Miao et al., 2016) . For some applications, such as learning density of images, dequantization can be applied to map discrete pixel values data to continuous distributions (Hoogeboom et al., 2020) . However, this approach is not applicable to categorical data with no intrinsic order.

Mixed type data that consist of categorical and continuous features pose additional challenges to density modeling (Nazabal et al., 2020) . Therefore, the proportion of categorical features should be taken into account when choosing an OOD detector.

The dimensionality of data is a crucial factor that influences the performance of density estimators. For example, standard kernel density estimators can achieve very good results on low-dimensional inputs but their performance degrades exponentially with an increased number of dimensions (Nagler and Czado, 2016; Wang and Scott, 2019). Other models, such as Autoencoder (AE) and Probabilistic Principal Component Analysis (PPCA) that perform dimensionality reduction by default are less affected by the number of features.

Having a large number of samples from which to estimate data distribution can unequally affect different density estimators. While most models benefit from having access to more data, algorithms such as Local Outlier Factor (LOF) that measure local 

In the classification setting, having unbalanced classes, which is very common for medical diagnostics, can negatively influence usefulness of learned data density. If there is not a sufficient number of samples of one class present in the training dataset, new samples of this minority class can be mistakenly flagged as OOD despite being an essential component of the dataset. While densities of two classes could be modeled separately or using a class-conditional density estimator (Sohn et al., 2015) , this approach is not feasible as we would have to first predict a sample's class and only then test whether the sample is in-distribution. Therefore, likelihood scores for underrepresented classes should be monitored when comparing different density models.

While any data point outside the training distribution is considered as OOD, it is not feasible to test against all possible inputs. Work by Zhang et al. (2021) argues that it is not theoretically possible to design a method that could detect all possible out-distribution inputs. Winkens et al. (2020) distinguished far -OOD and near -OOD depending on how similar inputs are to in-distribution data. Given that the latter group is more relevant and difficult to detect, we focus on near -OOD scenarios, specifying families of OOD groups that could be encountered in a medical setting in real life (Appendix Figure 9 ). We suggest to create clinically relevant OOD tests to cover the following categories (Table 1) :

• Detecting patients outside static inclusion-exclusion criteria (e.g. demographics).

• Detecting patients outside dynamic inclusion-exclusion criteria (e.g. a treatment protocol).

• Detecting patients with a new or underrepresented disease.

The OOD groups can be created either by using data eliminated under inclusionexclusion principle or by withholding specific groups from in-distribution ( Figure 1 ). 

Processing medical data involves defining inclusion and exclusion criteria that specify which samples are going to be part of the cohort to be analyzed. Inclusion criteria, which are typically clinical or demographic characteristics, must be present in order to include a sample. Exclusion criteria eliminate samples that passed inclusion criteria but have other characteristics that could invalidate downstream analysis (Patino and Ferreira, 2018). Inclusion-exclusion criteria can be used to evaluate the performance of OOD detection methods. Provided that models are trained only on samples that follow inclusionexclusion criteria, we can treat ineligible samples as OOD and compare how well these groups are flagged by OOD detectors. Such groups can be made using demographic or clinical characteristics ( Figure 1A ).

Another example of a clinically relevant OOD group is patients that should currently be excluded from data, but this status can change over time. In a medical setting, this is a common occurrence and can be caused by a change in the treatment protocol. If data about individual patients are available over a period of time, such groups can be created by finding a criterion that is not static and is subject to change. Alternatively, OOD groups can be created by splitting data on a received treatment.

A clinically relevant scenario that highlights the necessity of OOD detection methods is an occurrence of novel diseases. COVID-19 provides an example of the importance of being able to detect atypical symptoms in real-time instead of giving a prediction and only assessing data retrospectively. A common scenario occurs when a model is used for patients with a disease that was not sufficiently represented in the in-distribution data. We advise creating an OOD group of patients with underrepresented disease by either applying inclusion-exclusion criteria ( Figure 1A ) or withholding samples of patients with a specific disease from in-distribution training data ( Figure 1B ). 

Another consideration when deploying OOD detection methods is how transparent novelty predictions are. In high-stakes areas such as healthcare, it is not only useful to be able to flag a sample as OOD but also to see what set of features makes it different from in-distribution data. Some density estimators are inherently interpretable. For example, for AE-based models, it is possible to inspect features that received the highest reconstruction error. To provide a comparative evaluation of interpretability for all models, we suggest using Shapley Additive Explanations (SHAP; Lundberg and Lee, 2017).

We describe two approaches of assessing interpretability of OOD detection methods ( Figure 2 ). The first, dataset-level approach, splits data on one feature to divide in-distribution and OOD data. After scoring OOD samples, SHAP is used to determine feature importance for the assigned novelty scores. Models are then scored on the importance of the feature that was used for splitting ( Figure 2A ).

In the second, qualitative approach, OOD detectors are trained on in-distribution data and are used to score test data ( Figure  2B ). Samples that receive the highest novelty scores (outliers) are then inspected individually. Ranking the most influential features using SHAP and having medical professionals compare values of these features can help validate whether models are influenced by clinically relevant features and verify that outliers are indeed meant to be indistribution.

The ability to flag OOD samples in real-time, as compared to detecting batches of atypi-cal samples retrospectively, is an important consideration for the deployment of OOD detection methods. While inference time for individual predictions tends not be a limiting factor, when coupled with explainability tools such as SHAP, can significantly slow down the prediction process.

To illustrate the above-described principles in practice, we put them to test on the Ams-terdamUMC dataset. The downstream prediction task is a binary classification of readmission to ICU after discharge or mortality. 

In the following section we describe the results obtained applying the aforementioned methodology on the AmsterdamUMC data.

Dynamic Inclusion-Exclusion Criteria: Length of Stay. We followed the guidelines described in Section 3.2.2 and selected patients outside dynamic inclusionexclusion criteria which are subject to change in time. We used the fact that the Ams-terdamUMC dataset contains retrospective time series data for each patients. The indistribution data for this experiment are pa- Row labels indicate the number of days before discharge.

tients in the last day of their ICU admission and OOD groups are separated based on how far patients are from being discharged ( Figure 3 ). The further patients are from discharge, the more dissimilar their features are compared to in-distribution data. While all models except DUE showed the desired gradient of increasing AUC-ROC score, Flow achieved a near-perfect score already for patients 4-5 days before discharge. Dynamic Inclusion-Exclusion Criteria: Discharge Destination. Given that the main predictive task is classification of readmission probability, patients that died at the ICU or were transferred to another department or a different hospital are excluded from in-distribution data.

Most models detected patients with discharge destination of mortuary more easily than patients that were transferred to an ICU of a different hospital (Appendix Figure 5) . This result is reassuring as, arguably, features of transferred patients more closely resemble in-distribution data.

Dynamic Inclusion-Exclusion Criteria: Received Treatment. Next, we selected patients outside dynamic inclusionexclusion criteria based on the type of received treatment. We compared the OOD detection methods on two categories of treatment-related exclusion criteria: patients connected to a specific device and patients receiving medication interventions.

We first tested whether novelty detectors are able to flag patients connected to a ventilating machine and continuous veno-venous hemofiltration (CVVH) device ( Figure 4 ). Note that in our experiment, there are no features that would directly indicate whether patients are ventilated or on CVVH, and therefore, OOD detectors must infer this information from the rest of the features. While most models are assigning greater novelty scores to the OOD groups, Flow model has the least overlapping distributions for the groups and in-distribution test data ( Figure  4 , bottom panel). We also compared how the detection of the ventilated patients changes in time as they get closer to discharge (Appendix Figure 6 ).

To test medication-related OOD detection, we evaluated the models in detection patients that fall outside of inclusionexclusion criteria due to administration of inotropic or vassopressor medication (Appendix Figure 7) . Flow flagged these patients with AUC as high as 0.97-0.98%

Observing Patients with New Diseases. We use data from the same ICU containing confirmed and suspected COVID-19 patients collected as part of the Dutch Data Warehouse (Fleuren et al., 2021) to test OOD detectors in their ability to flag patients with this disease (Appendix Figure  8 ). While AE, PPCA, and VAE achieved AUC-ROC above 70% for COVID-19 patients, Flow was able to achieve over 90% for both COVID-19 patients and suspects.

Inference Time for Real-Time Predictions. Given that predictions about the novelty of a sample are most useful when given in real-time, we timed OOD detectors in predicting a novelty score for a single sample and when coupled with SHAP (See Appendix Table 2 ). AE and PPCA are almost 30 times faster in inference and SHAP calculations than the other methods.

While it is standard practice to evaluate predictive models on each dataset, there is no established way to compare different OOD detection methods. In this paper, we described a set of practical guidelines on how to create and test OOD detection methods on medical tabular data.

A similar effort in bridging the gap between research studies and practical implementation was shown for other critical areas such as AI explainability. Mohseni et al. There are many outstanding questions related to design and selection of OOD detection methods. First, to our knowledge, there is no direct solution to class imbalance of in-distribution data for OOD detection and current methods have to rely on availability of sufficiently large sample size. Second, current models are not well suited for dealing with mixed-type data containing categorical and continuous distributions as they require different likelihood functions. Extending density estimators to mixed-type data (Nazabal et al., 2020; Ma et al., 2020) could greatly enhance OOD detection results. Third, more efficient ways to deal with feature correlation can improve evaluation of interpretability of OOD detectors to prevent feature-importance spread (Lundberg and Lee, 2017; Aas et al., 2021).

The setup described here assumes some prior knowledge about the possible OOD groups that should be detected as near -OOD (Winkens et al., 2020) . In addition, we acknowledge that apart from tests described in this paper, other clinically relevant scenarios include detecting samples from different hospitals, and testing for corrupted features (see for example Ulmer et al. (2020) ).

How to aggregate results of different OOD tests and select the most reliable OOD detector across the results is another open-ended and application-specific question. In our experiments on real-life mixed-type EHR data, Flow and VAE performed consistently well across different OOD tests. Given that the performance of density estimators depends on the type of data and dimensionality of the dataset (see Section 3.1), the superior performance of these two models can be explained by a relatively low number of categorical features (less than 10%), potential non-linear interactions of different features (which could be more problematic for PPCA), and large data size (which can make LOF less efficient). Recently, failures of normalizing flows in assigning higher likelihood to OOD inputs were discussed by several papers (Kirichenko et al., 2020; Zhang et al., 2021; Nalisnick et al., 2019) . We hypothesize that structured data such as images that give rise to local pixel correlations are more prone to such failures than tabular data.

Finally, the guidelines for evaluating OOD detectors for medical data described in this paper can help OOD detectors bridge the gap from theoretical possibility to deployed application, enhancing the safety of AI tools and facilitating the uptake of this new technology in the medical field. based on the admission day at the ICU. In-distribution data for this experiment are eligible patients at their last day at the ICU (AmsterdamUMC-DIS). To create OOD groups, we used AmsterdamUMC-ROW dataset. For each patient we computed the total length of stay at the ICU and bracketed samples based on the number of days before discharge of each patient. Given that patients stayed at the ICU for different number of days, the groups of patients with the highest number of days before discharge contained fewer patients (see patient counts listed in Figure 3 ).

We created four OOD groups by applying the inclusionexclusion criteria of discharge destination. In-distribution data for this experiment are eligible patients in the AmsterdamUMC-DIS-II dataset. We split excluded patients into four groups: patients transferred to Critical Care Unit (CCU) or ICU of another hospital contained (n = 245) patients, a group of patients that were transferred to another hospital contained (n = 456) patients, and two groups of patients that died at the ICU and were sent to a mortuary either with autopsy (n = 4) or without (n = 6).

Received treatment: devices. To split patients on a received device-related treatment, we separated patients based on whether they are connect to a ventilator device (n = 15, 374) or to CVVH (n = 1, 610). In-distribution data for this experiment are eligible patients in the AmsterdamUMC-ROW dataset.

Received treatment: medication. To split patients on a received medicationrelated treatment we separated patients who were administered Enoximone (n = 57) or Norepinephrine (n = 774) in the last 24 hours.

In-distribution data for this experiment are eligible patients in the AmsterdamUMC-ROW dataset.

To create OOD group with of patients with a new disease on AmsterdamUMC, we used groups of COVID-19 patients (n = 130) and COVID-19 suspects (n = 140) which fall outside exclusion criteria. In-distribution data for this experiment are eligible patients in the AmsterdamUMC-ROW dataset.

Given that discriminator models were shown to underperform on OOD detection for medical tabular data (Ulmer et al., 2020) , we limited our analysis to density estimators. We included models that do not model explicit density function, such as Autoencoder and Local Outlier Factor (LOF).

Autoencoder. AE was used in combination with a reconstruction error metric. This metric was chosen because it is expected that the model will learn to encode training distribution faithfully whereas samples that are different from training data will not be reconstructed properly and will receive a high reconstruction error. For the AmsterdamUMC dataset, we used the following hyperparameters: both encoder and the encoder had 1 layer with 75 units, the latent space contained 20 dimensions, and the learning rate was 0.007.

Variational Autoencoder. We implemented a Variational Autoencoder (VAE), one of the most popular density estimation techniques, (Kingma and Welling, 2014). Similar to AE, the novelty metric was chosen to be reconstruction error. For experiments on AmsterdamUMC, we used the following hyperparameters: encoder and the encoder contained 3 layers each with 25 units, the latent space contained 10 dimensions, and the learning rate was 0.001. Additionally, we used beta-annealing (a deterministic warmup; Huang et al., 2018) .

Probabilistic Principal Component Analysis. We used Probabilistic Principal Component Analysis (PPCA; Tipping and Bishop, 1999) as a latent variable model with a log likelihood metric. The hyperparameter for PPCA model was only the number of components which was selected as 19 for AmsterdamUMC.

Deep Neural Gaussian Process. We implemented a deep neural Gaussian Process model called Deterministic Uncertainty Estimation (DUE) according to (van Amersfoort et al., 2021) . This approach builds on the idea of feature-distance awareness which denotes ability of model to quantify distance of new samples to training data. DUE uses a distance-preserving neural network for feature extraction and models uncertainties using a Gaussian Process in the last layer. Standard deviation was used a novelty metric. The hyperparameters that were used for AmsterdamUMC data were the following: we used the Matern 12 kernel function with 50 inducing points, feature-extracting neural network consisted of 4 layers with 256 units, we set the Lipschitz coefficient at 0.5, and the learning rate at 0.002.

Normalizing Flows. Normalizing flow models are tractable explicit density estimators that learn training data distribution by series of transformations into a normal distribution. We used Masked Autoregressive Flow as described in (Papamakarios et al., 2018) from an open-source implementation available at (Durkan et al., 2020) . The hyperparameters were selected to be the following: 20 layers of composite transformations and reverse permutation, the number of hidden units was 256, we used batch normalization between layers, and the learning rate was set to 0.001.

Local Outlier Factor. LOF (de Vries et al., 2010) does not model density function of training data, it expresses local density of features of a sample and compares this den-sity to closest neighbors. The novelty score is then an average local reachability density of the neighbors denoted as outlier score. The only tunable hyperparameter is the number of closest neighbors which was set to 5.

Below, we show figures of the following experiments performed on the Amsterda-mUMC which were described in Section 4:

• Dynamic Inclusion-Exclusion Criteria:

Discharge Destination (Appendix Figure 5 ).

• Dynamic Inclusion-Exclusion Criteria: Days of Ventilation (Appendix Figure  6 ).

• Dynamic Inclusion-Exclusion Criteria: Medication (Appendix Figure 7 ).

• New disease: COVID-19 patients (Appendix Figure 8 ). Figure 5 : AUC-ROC scores of detecting patients that died at the ICU (Mortuary with or without autopsy) and patients that were transferred to another hospital (ICU or other department). This experiment was performed on the AmsterdamUMC-DIS-II dataset (see dataset description in Appendix A.1) which contains more categorical features than AmsterdamUMC-DIS used for the above-described experiments. This could explain the poor performance of Flow in detecting Mortuary with autopsy patients as the model is not suitable for categorical data. age  alanine_transaminase__mean__last_24h  albumin__mean__last_24h__padded  alkaline_phosphatase__mean__last_24h  amylase__mean__last_24h  arterial_blood_pressure_diastolic__mean__last_24h  arterial_blood_pressure_systolic__mean__last_24h  aspartate_transaminase__mean__last_24h  base_excess__mean__last_24h  bicarbonate_arterial__mean__last_24h  bilirubin_total__mean__last_24h  c_reactive_protein__mean__last_24h  calcium_ionised__mean__last_24h  cardiac_output__is_measured__last_24h  cardiac_output__maximum__last_24h  cardiac_output__minimum__last_24h  chloride__mean__last_24h  cough_stimulus__mode__last_24h__cough_reflex_normal  cough_stimulus__mode__last_24h__cough_reflex_reasonable  cough_stimulus__mode__last_24h__cough_reflex_weak  creatinine__last__overall  fio2__mean__last_24h  fluid_out_urine__total_dose__last_24h  gender_M  gender_V  glasgow_coma_scale_total__maximum__last_24h  glasgow_coma_scale_total__minimum__last_24h  glucose__mean__last_24h  heart_rate__mean__last_24h  hemoglobin__mean__last_24h  lactate_dehydrogenase__mean__last_24h  lactate_unspecified__last__overall  leukocytes__mean__last_24h__padded  magnesium__mean__last_24h  neutrophils__mean__last_24h  o2_flow__mean__last_24h  o2_saturation__mean__last_24h  pao2_over_fio2__mean__last_24h  pco2_arterial__mean__last_24h  ph_arterial__mean__last_24h  phosphate__mean__last_24h  potassium__mean__last_24h  respiratory_rate_measured__mean__last_24h  richmond_agitation_sedation_scale_score__maximum__last_24h  richmond_agitation_sedation_scale_score__minimum__last_24h  sodium__mean__last_24h  temperature_blood__mean__last_24h  temperature_internal__maximum__last_24h  temperature_internal__minimum__last_24h  thrombocytes__mean__last_24h  tidal_volume__mean__last_24h  time_since_start  troponin_t__is_measured__last_24h  troponin_t__maximum__last_24h  ureum__mean__last_24h  ureum_over_creatinine__mean__last_24h 

Elbers. The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients

Association for Computing Machinery

We would like to thank our colleagues at Pacmed and Amsterdam UMC for providing us with the data and insights. We also thank Dennis Ulmer for providing valuable feedback on the manuscript. 

We used a dataset from Amsterdam University Medical Center (AmsterdamUMC). This dataset was chosen to illustrate a real-life medical use case of EHR data, which typically has a lot of features, including categorical, and an unbalanced outcome.AmsterdamUMC has released a freely accessible de-identified version of the data from 2003-2016. Access to the data and/or the Dutch Data Warehouse against COVID-19 can be requested from Amsterdam Medical Data Science (https://amsterdammedicaldatascience.nl/).AmsterdamUMC dataset contains retrospective data of patients admitted to Intensive Care Unit (ICU) for each day of their admission stay. This results in 58, 142 rows of data corresponding to 15, 753 patients. For some analyses we sub-select rows of data for patients in their last day of admission at the ICU. We refer to this part of the dataset as AmsterdamUMC-DIS and to the full dataset as AmsterdamUMC-ROW. After eliminating ineligible patients using inclusionexclusion criteria, AmsterdamUMC-ROW dataset contained n = 40, 923 patients and AmsterdamUMC-DIS contained n = 15, 695 patients.The total number of features in the dataset is 5269. Features were created by analyzing time series and dividing data into windows of 24 hours. We selected 56 features of which 49 are continuous and 7 categorical. For model training and hyperparameter search, we used a a 0.7, 0.15, 0.15, split for train, validation, and test split, respectively. All feature names used are shown in the list A1.1 at the end of the document For the experiment in Figure 7 , a second version of AmsterdamUMC dataset was used with n = 18, 064 patients at their last day of ICU admission and 150 features. This selec-tion includes 84 categorical features and 66 continuous features. We refer to this dataset as AmsterdamUMC-DIS-II. After applying inclusion-exclusion criteria, the dataset contained n = 17, 482 patients.

Our main goal is to find the best OOD detectors to flag samples that are not well represented in the training data, and which should not receive a prediction. We define this downstream prediction task to be a binary classification of patients who died or were readmitted back to the ICU within 7 days after discharge. Given that the dataset provides labels of readmission or mortality after discharge for each patient, any predictive model can be trained for this task. The dataset contains 4.9% of patients who were readmitted or died at the ICU. Samples of patients at the last day of admission (AmsterdamUMC-DIS) are used for training predictive models. The rationale for this choice is that the predictive model should be used when clinicians are already considering discharge of a patient from the ICU.

We use AUC-ROC scores to report the performance of OOD detection methods. First, models are trained on in-distribution training data. Then, they are used to predict novelty scores of in-distribution testing data and each samples in each OOD group. The scores of test in-distribution data and an OOD group are then used to calculate AUC-ROC score by assigning a label 0 to all indistribution samples and a label of 1 to all samples in an OOD group.

Length of stay.For the Amsterda-mUMC dataset, we created OOD groups